We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.64
Bid: 41.48
Ask: 41.54
Change: 0.74 (1.81%)
Spread: 0.06 (0.145%)
Open: 42.08
High: 42.08
Low: 41.20
Prev. Close: 40.90
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

2 Jul 2019 07:00

RNS Number : 1070E
Assura PLC
02 July 2019
 

2 July 2019

Assura plc

 

Trading Update

For the first quarter to 30 June 2019

 

Assura's high-quality portfolio and pipeline reinforced; GPI integration progressing well

 

Assura plc ("Assura"), the leading primary care property investor and developer, today announces its Trading Update for the first quarter to 30 June 2019.

 

Jonathan Murphy, CEO, said:

"Assura made good progress in the first quarter, further enhancing our high-quality portfolio of primary care properties. Our immediate pipeline of developments and acquisitions has never been stronger, while we disposed of 12 properties that were held for sale for cash proceeds of £17 million which was above book value.

 

"In May, we completed the purchase of primary care developer GPI and welcomed a talented new team into Assura. The acquisition boosted our immediate and extended development pipeline by an initial £92 million.

 

"We continue to source exciting opportunities to grow our portfolio and provide more of the fit-for-purpose primary care facilities that the NHS urgently needs to benefit patients and reduce pressure on the organisation.

 

"We remain confident in our outlook for the full year and in our longer-term prospects."

 

Developments and strategic acquisitions strengthen market-leading portfolio

· One development completed (Darley Dale) at a cost of £2.3 million and two moved to on site (Canterbury and St Leonards); total of 12 developments on site at the period end with a total development cost of £58 million.

· Two acquisitions completed in the period at a cost of £5.5 million.

· 12 disposals completed for £17 million cash consideration at a small premium to book value.

 

GPI acquisition expands pipeline

· Current portfolio of 554 properties.

· Immediate development pipeline of £77 million.

· Immediate acquisitions pipeline increased to £64 million, compared with £41 million at March 2019.

· Total immediate pipeline value, including on site developments, of £199 million up from £142 million at the year end.

 

Active portfolio management delivering value

· Six lease re-gears agreed on £0.3 million of rent, adding weighted average of 10 years WAULT on those properties.

· Annualised rent roll at £102.1 million post disposals.

 

Strong financial position

· As at 30 June 2019 gross debt £730 million with undrawn facilities of £230 million plus cash balance of £47.5 million.

 

 

 

ENDS

For further information, please contact:

 

Assura plc:

Jayne Cottam, CFOOrla Ball, Company SecretaryDavid Purcell, Head of Financial Reporting

 

Tel: 01925 420 660

 

Finsbury:

Gordon Simpson

James Thompson

 

Tel: 0207 251 3801

 

This announcement contains inside information as defined in Article 7 of the EU Market Abuse Regulation No 596/2014 and has been announced in accordance with the Company's obligations under Article 17 of that Regulation.

 

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 31 March 2019, Assura's property portfolio was valued at £1,979 million.

 

Further information is available at www.assuraplc.com

 

*EPRA is a registered trademark of the European Public Real Estate Association.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTLLFLRDEILIIA
Date   Source Headline
12th Jul 20227:00 amRNSAdditional Listing
11th Jul 20227:00 amRNSScrip Dividend Declaration
7th Jul 20228:07 amRNSHolding(s) in Company
6th Jul 20225:18 pmRNSDirector/PDMR Shareholding
6th Jul 20225:06 pmRNSHolding(s) in Company
6th Jul 20223:32 pmRNSResult of AGM
6th Jul 20228:57 amRNSHolding(s) in Company
6th Jul 20227:00 amRNSTrading Update
16th Jun 20229:45 amRNSScrip Calculation Price
7th Jun 20227:00 amRNSDirector/PDMR Shareholding
1st Jun 20227:00 amRNSAnnual Report & Notice of AGM
31st May 20221:58 pmRNSDirector/PDMR Shareholding
31st May 20227:00 amRNSNotice of Dividend
24th May 20227:00 amRNSAssura Full Year Results 2022
17th May 20225:41 pmRNSHolding(s) in Company
16th May 20224:36 pmRNSChange to year end results announcement date
12th May 20225:15 pmRNSHolding(s) in Company
12th May 20227:00 amRNSUpdated results presentation timing
9th May 20229:06 amRNSDirector/PDMR Shareholding
6th May 202211:46 amRNSHolding(s) in Company
4th May 20223:17 pmRNSHolding(s) in Company
4th May 20229:31 amRNSHolding(s) in Company
29th Apr 202211:58 amRNSTotal Voting Rights
29th Apr 202211:56 amRNSHolding(s) in Company
22nd Apr 20227:00 amRNSIssue of Consideration Shares
21st Apr 20223:01 pmRNSDirector/PDMR Shareholding
21st Apr 20227:00 amRNSNotice of Results & Investor Presentations
12th Apr 20228:50 amRNSHolding(s) in Company
11th Apr 202211:10 amRNSDirector/PDMR Shareholding
11th Apr 20228:47 amRNSHolding(s) in Company
11th Apr 20227:00 amRNSScrip Dividend Declaration
6th Apr 202210:30 amRNSStandard form for notification of major holdings
6th Apr 20227:00 amRNSIssue of Consideration Shares
1st Apr 20227:00 amRNSDevelopment Update
22nd Mar 202210:07 amRNSHolding(s) in Company
18th Mar 20221:49 pmRNSScrip Calculation Price
16th Mar 20227:00 amRNSDevelopment Update
8th Mar 20222:57 pmRNSHolding(s) in Company
8th Mar 20222:01 pmRNSDirector/PDMR Shareholding
3rd Mar 20227:00 amRNSNotice of Dividend
9th Feb 20223:52 pmRNSHolding(s) in Company
9th Feb 20221:15 pmRNSDirector/PDMR Shareholding
1st Feb 20229:08 amRNSTotal Voting Rights
18th Jan 20223:14 pmRNSDirector/PDMR Shareholding
10th Jan 20227:00 amRNSScrip Dividend Declaration
10th Jan 20227:00 amRNSTrading Update
7th Jan 20223:41 pmRNSDirector/PDMR Shareholding
16th Dec 20219:27 amRNSScrip Calculation Price
8th Dec 20214:05 pmRNSHolding(s) in Company
7th Dec 202110:55 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.